cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Cytek Biosciences Inc
1 own
2 watching
Current Price
$11.93
$0.29
(2.49%)
logo-ctkb
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,608.75M
52-Week High
52-Week High
16.05
52-Week Low
52-Week Low
7.38
Average Volume
Average Volume
0.38M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,608.75M
icon52-Week High16.05
icon52-Week Low7.38
iconAverage Volume0.38M
iconDividend Yield--
iconP/E Ratio--
What does the Cytek Biosciences Inc do?
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Read More
How much money does Cytek Biosciences Inc make?
News & Events about Cytek Biosciences Inc.
Globe Newswire
2 months ago
New Digital Ecosystem Supports Full Spectrum Flow Cytometry Research from Panel Design to Data Acquisition Cytek Cloud Cytek Cloud is the new digital ecosystem that supports full spectrum flow cytometry research from panel design to data acquisition. FREMONT, Calif., Nov. 15, 2022 (GLOBE ...
Ticker Report
3 months ago
Cytek Biosciences, Inc. (NASDAQ:CTKB Get Rating) CFO Patrik Jeanmonod sold 3,500 shares of the businesss stock in a transaction dated Monday, October 24th. The stock was sold at an average price of $15.16, for a total value of $53,060.00. Following the sale, the chief financial ...
Globe Newswire
3 months ago
FREMONT, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Cytek Biosciences or Cytek) (Nasdaq: CTKB), today announced the company will be participating in the upcoming 31st Annual Credit Suisse Healthcare Conference in Rancho Palos Verdes, CA. Cyteks management is scheduled to ...
PR Newswire
6 months ago
Kunlun Capital Helps Medical Companies Grow in the Long Run Kunlun Capital Helps Medical Companies Grow in the Long Run PR Newswire BEIJING, July 12, 2022 BEIJING, July 12, 2022 /PRNewswire/ --Recently, Yahui Zhou, the founding partner of Kunlun Capital, won the 36kr 2022 ' China 100 Best...
Ticker Report
7 months ago
Cytek Biosciences, Inc. (NASDAQ:CTKB Get Rating) CEO Wenbin Jiang sold 20,000 shares of the businesss stock in a transaction dated Tuesday, June 7th. The shares were sold at an average price of $10.75, for a total value of $215,000.00. Following the completion of the transaction, the ...
Frequently Asked Questions
Frequently Asked Questions
What is Cytek Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Cytek Biosciences Inc shares?
plus_minus_icon
How can I buy Cytek Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Cytek Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Cytek Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Cytek Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Cytek Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Cytek Biosciences Inc?
plus_minus_icon
What percentage is Cytek Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Cytek Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$11.93
$0.29
(2.49%)
logo-ctkb
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00